ConductScience.org, home

Paper · 218118

Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.

Schrör K and 1 other. Naunyn Schmiedebergs Arch Pharmacol, 1979. Cited by 31 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries. Papers, record 218118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/218118

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.55
iCite
Revised in PubMed
2019-07-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schrör KK
2Rösen PP

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood VesselsMajor topic
Cyclic AMPMajor topic
EpoprostenolMajor topic
ProstaglandinsMajor topic
Adenosine
Animals
Cattle
Coronary Vessels
In Vitro Techniques
Muscle Relaxation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,347,988Adenyl cyclase-phosphodiesterase system in arterial smooth muscle.Life Sci I1972https://conductscience.org/library/papers/4347988PubMed
2366,105Prostacyclin: a potent coronary dilating agent in the rat isolated heart [proceedings].J Physiol1978https://conductscience.org/library/papers/366105PubMed
3338,313Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.Eur J Pharmacol1978https://conductscience.org/library/papers/338313PubMed
4841,106Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.Prostaglandins1977https://conductscience.org/library/papers/841106PubMed
5179,331Adenosine relaxation of isolated vascular smooth muscle.Am J Physiol1976https://conductscience.org/library/papers/179331PubMed
663,657Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.Lancet1977https://conductscience.org/library/papers/63657PubMed
7339,097Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart.Nature1977https://conductscience.org/library/papers/339097PubMed
8191,877Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.Prostaglandins1977https://conductscience.org/library/papers/191877PubMed
94,330,512Cyclic AMP and smooth muscle function.Ann N Y Acad Sci1971https://conductscience.org/library/papers/4330512PubMed
10197,414Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.Nature1977https://conductscience.org/library/papers/197414PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
7,037,509Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs.Diabetologia1982https://conductscience.org/library/papers/7037509PubMed
7,023,464Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts.Basic Res Cardiol1981https://conductscience.org/library/papers/7023464PubMed
6,268,056Possible role of prostaglandins in the regulation of coronary blood flow.Basic Res Cardiol1981https://conductscience.org/library/papers/6268056PubMed
6,154,247Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.Naunyn Schmiedebergs Arch Pharmacol1980https://conductscience.org/library/papers/6154247PubMed
6,095,805Uptake and efflux of calcium by canine coronary arteries and the action of adenosine.Basic Res Cardiol1984https://conductscience.org/library/papers/6095805PubMed
91,976PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.Naunyn Schmiedebergs Arch Pharmacol1979https://conductscience.org/library/papers/91976PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/218118

GET https://conductscience.org/api/papers/v1/218118/authors